The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.5M data for 737K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

7 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
The recent advance of Interleukin-1 receptor associated kinase 4 inhibitors for the treatment of inflammation and related diseases.EBI
Children's Hospital Affiliated to Zhengzhou University
Discovery of N-(2-oxoethyl) sulfanilamide-derived inhibitors of KAT6A (MOZ) against leukemia by an isostere strategy.EBI
Children's Hospital Affiliated to Zhengzhou University
A comprehensive review of new small molecule drugs approved by the FDA in 2022: Advance and prospect.EBI
Children's Hospital Affiliated to Zhengzhou University
Synthetic approaches and application of clinically approved small-molecule drugs to treat hepatitis.EBI
Children's Hospital Affiliated to Zhengzhou University
Oxazolidinone: A promising scaffold for the development of antibacterial drugs.EBI
Children's Hospital Affiliated to Zhengzhou University
Discovery of N-Substituted Acetamide Derivatives as Promising P2Y14R Antagonists Using Molecular Hybridization Based on Crystallographic Overlay.EBI
Children's Hospital Affiliated to Zhengzhou University
Discovery of novel tubulin/HDAC dual-targeting inhibitors with strong antitumor and antiangiogenic potency.EBI
Children'S Hospital Affiliated To Zhengzhou University